# Bausch Health's Gastroenterology Business, Salix, to Present New Data on Cirrhosis Trends and Severe Alcohol-Associated Hepatitis at The Liver Meeting® 2026

- Source: PR Newswire M&A
- Published: 2026-11-06T12:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/bausch-healths-gastroenterology-business-salix-to-present-new-data-on-cirrhosis-trends-and-severe-alcohol-associated-hepatitis-at-the-liver-meeting-2026-302931186.html
- Canonical: https://groundlevelnews.com/story/bausch-health-s-gastroenterology-business-salix-to-present-new-data-on-6bc535/

LAVAL, QC, Nov. 6, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, will present a research poster at the American Association for the Study of Liver Diseases' The Liver Meeting® 2026, November 5–9 in...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._